<DOC>
	<DOCNO>NCT02085122</DOCNO>
	<brief_summary>Introduction : Dyspnea fatigue determine exercise intolerance heart failure ( HF ) subject , hamper performance activity daily live . In context , noninvasive ventilation ( NIV ) use minimize impairment , increase functional capacity Aim : To evaluate impact NIV exercise performance HF individual . Methods : A randomized crossover clinical trial allocation concealment consist two experimental phase : NIV control , 7 day apart . During NIV phase , 30 minute bi-level ventilation perform . Any type ventilator support offer control phase . Functional capacity assess cardiopulmonary exercise test treadmill .</brief_summary>
	<brief_title>Exercise Noninvasive Ventilation Heart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Both sex , 1860 year body mass index ( BMI ) &lt; 30 kg/m2 functional class IIIII accord New York Heart Association echocardiogram últiimos 6 month show ejection fraction ( LVEF ) ≤ 45 % echocardiogram six month show cardiac hypertrophy ( left Ventricular Diastolic Diameter ( LVDD ) &gt; 55mm Diameter Systolic leave Ventricular ( LVSD ) &gt; 45mm ) optimize point view drug ( 6 ) clinical stability ( 1 ) unstable angina , myocardial infarction heart surgery three month begin research ( 2 ) chronic orthopedic , infectious metabolic disease ( 3 ) FEV1/FVC &lt; 70 % predict characterize obstructive respiratory disorder ; ( 4 ) active smoker ( 5 ) Limitation use NIV : claustrophobia , inability remain mouth close , abdominal distention , hemodynamic instability , heart rate ( HR ) &lt; 60 bpm , recent trauma , nausea vomit face</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>